LOS ANGELES, April 02, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against agilon health, inc. ("agilon" or "the Company") (NYSE:AGL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors who purchased the Company's securities between January 9, 2023 and January 4, 2024, inclusive (the "Class Period"), or purchased or otherwise acquired agilon common stock pursuant, or traceable to materials issued in connection with the Company's secondary public offering (the "SPO Materials") that occurred on or about May 16, 2023.are encouraged to contact ...